Core Points - The company received a warning letter from the Ningbo Securities Regulatory Bureau due to failure to timely perform review procedures for related party transactions [1] - The company reported sales of 195.5255 million yuan to a new related party, exceeding the expected amount by 105.5255 million yuan, which is 5.13% of the company's audited net assets for 2023 [1] - The company violated regulations regarding information disclosure management for listed companies, with the board secretary held primarily responsible for the violations [1]

证券代码：605008 证券简称：长鸿高科 公告编号：2025-032 宁波长鸿高分子科技股份有限公司 关于为控股子公司提供银行授信担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 被担保人名称:浙江长鸿生物材料有限公司（以下简称"长鸿生物"或"子 公司"） 本次担保金额及已实际为其提供的担保余额:宁波长鸿高分子科技股份 有限公司（以下简称"公司"或"长鸿高科"）本次为长鸿生物担保金额为人民 币 41,000 万元。截至目前，公司已实际为其提供的担保余额为 9.75 亿元。 一、担保情况概述 （一）担保基本情况 近日，公司与交通银行股份有限公司宁波分行签署了《保证合同》。公司以 连带责任保证方式为债务人长鸿生物提供自 2025 年 05 月 15 日起至 2030 年 05 月 15 日期间签订的全部主合同提供最高额 4.1 亿元的保证担保，并将 2025 年 05 月 15 日前未结清债务均纳入新的担保合同。 （二）已经履行的审议程序 2025 年 3 月 19 日，公司召开第三届董事会第十六次 ...

Group 1 - BYD reported August sales of 174,915 new energy vehicles, a year-on-year increase of 184.84% [1] - Cumulative sales from January to August reached 978,795 units, representing a year-on-year growth of 267.31% [1] - The company sold 5,092 new energy passenger vehicles overseas in August [1] Group 2 - Zhongke Electric's subsidiary plans to establish a joint venture with Chongqing Fudi for the production of anode materials, with a registered capital of 1 billion RMB [2] - Zhongke Electric's subsidiary will contribute 650 million RMB, while Chongqing Fudi will contribute 350 million RMB [2] Group 3 - Yuyuan Group intends to transfer 13% of its shares in Jinhuijiu for approximately 1.937 billion RMB, reducing its stake to 25% [3] - The company plans to further reduce its holdings by more than 5% within the next six months [3] Group 4 - Lizhu Group's recombinant COVID-19 fusion protein vaccine has been included in the emergency use for sequential booster immunization [4] Group 5 - Guanghui Energy plans to repurchase shares worth between 800 million and 1 billion RMB to support employee stock ownership plans [5] Group 6 - Cambrian has launched four cloud-based intelligent chips, although mass sales will require a longer time frame and initial technical service investments [7] Group 7 - LePu Medical has received approval from the China Securities Regulatory Commission for the issuance of Global Depositary Receipts (GDRs) and listing on the Swiss Stock Exchange [9] - The GDR issuance will correspond to no more than 180,458,875 new A-shares [9] Group 8 - Fushi Holdings' subsidiary has entered into an exclusive advertising agency cooperation with the Central Radio and Television Station's automotive channel for three years [10] Group 9 - Guangzhou Port's container throughput in August was 1.981 million TEUs, a year-on-year increase of 2.4% [11] - The total cargo throughput for August was 44.788 million tons, a decrease of 0.6% [11] Group 10 - Ningbo Port expects to complete a container throughput of 3.58 million TEUs in August, a year-on-year increase of 10.2% [12] - The total cargo throughput is projected to decline by 3.0% [12] Group 11 - Ming Tai Aluminum reported a 7% year-on-year decrease in aluminum plate and strip sales in August, while aluminum profile sales increased by 47% [13] Group 12 - Electric Power Investment plans to invest in multiple wind and solar projects, with total static investments of 1.585 billion RMB for wind and 538 million RMB for solar [14] Group 13 - Northeast Pharmaceutical has signed a cooperation agreement with MedAbome for the development of the MAb11-22.1 antibody project [19] Group 14 - New Five Feng plans to acquire equity in Tianxin Seed Industry and several other companies for a total price of approximately 2.208 billion RMB [26] Group 15 - Sumeida's subsidiary plans to transfer 100% equity of eight photovoltaic power station project companies, with an estimated transaction value of 657 million RMB [27] Group 16 - *ST Tongzhou intends to acquire 51% equity in Tongtaiwei, fulfilling the capital contribution obligation of 10.2 million RMB [29] Group 17 - Tianyin Holdings' subsidiary plans to invest 120 million RMB in Xundong Xintong to acquire 40% equity [30] Group 18 - Hainan Haiyao plans to publicly transfer 43% equity in Shanghai Lishengte to attract new investors [31] Group 19 - New Asia Process plans to transfer 7.76% of its shares to Xiangcai New Materials at a price of 5.274 RMB per share [32] Group 20 - Lanwei Medical plans to raise no more than 664 million RMB through a private placement for provincial laboratory construction projects [34] Group 21 - Lida New Materials plans to issue convertible bonds to raise no more than 300 million RMB for a new aluminum material project [35] Group 22 - Gekewei has successfully launched its 12-inch CIS integrated circuit project, achieving over 95% yield [51] Group 23 - Baijin Medical's tricuspid valve ring product has received registration approval [52] Group 24 - Shanghai Pharmaceuticals has received approval to initiate Phase I clinical trials for a recombinant anti-CD20 humanized monoclonal antibody [53] Group 25 - Junda Co. has increased the production capacity of its solar cell production base project from 8GW to 10GW [54]

Group 1 - The core point of the announcement is the confirmation of daily related transactions between the company and Zhejiang Huawai Chemical Sales Co., Ltd, which requires shareholder meeting approval due to exceeding 5% of the audited net assets [1][2] - The confirmed related transaction amount is 195.5255 million yuan, which is significantly higher than the annual estimated amount of 90 million yuan [1][2] - The company asserts that the pricing of the transactions is fair and does not harm the interests of the company and its shareholders, especially minority shareholders [1][4] Group 2 - The independent directors of the company have agreed that the related transactions are necessary for daily operations and do not significantly impact the financial status or independence of the company [2][4] - The related party, Zhejiang Huawai Chemical, is a limited liability company established on October 9, 2023, with a registered capital of 10 million yuan [2][3] - The actual controller's son holds a senior management position at Huawai Chemical, establishing a related relationship as per the Shanghai Stock Exchange regulations [3]

Core Viewpoint - The report from Yongxing Securities confirms the daily related transactions between Ningbo Changhong Polymer Technology Co., Ltd. and Zhejiang Ningbo Huawai Chemical Sales Co., Ltd., emphasizing that the transactions are fair and do not harm the interests of the company or its shareholders, particularly minority shareholders [1][4]. Group 1: Daily Related Transactions Overview - The total amount of related transactions between the company and Huawai Chemical is 195.5255 million yuan, exceeding the annual expected amount of 90 million yuan by more than 5% of the audited net assets [1]. - The independent directors of the company have agreed that the related transactions are necessary for daily operations and have followed principles of openness, fairness, and justice [1][2]. Group 2: Related Party Information - Huawai Chemical, established on October 9, 2023, has a registered capital of 10 million yuan and is involved in the sales of chemical products and general cargo storage services [2]. - The relationship is established through the son of the company's actual controller, who will serve as a senior manager at Huawai Chemical starting April 2024, aligning with the regulations of the Shanghai Stock Exchange [2]. Group 3: Transaction Terms and Pricing Policy - The transactions are characterized as market-based commercial activities, with pricing based on market standards, ensuring no harm to the company or its shareholders [3][4]. - The transactions are deemed normal for production and operational needs, maintaining the company's independence and not creating significant reliance on the related party [4]. Group 4: Review Opinions from the Sponsor Institution - The sponsor institution has confirmed that the related transactions have been approved by the company's board and supervisory committee, with related directors abstaining from voting, and that the decision-making process complies with relevant laws and regulations [4].

Meeting Information - The shareholder meeting is scheduled for June 3, 2025, at 14:00 [1] - The meeting will be held at 102 Xinhui Road, High-tech Zone, Yinzhou District, Ningbo, Zhejiang Province [1] - Voting will be conducted through a combination of on-site and online methods [1] Voting Procedures - The online voting system used will be the Shanghai Stock Exchange's shareholder meeting online voting system [2] - Voting will be available from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders can vote via designated trading securities companies or through the internet voting platform [2] Shareholder Eligibility - Only shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch after the close of trading on May 27, 2025, are eligible to attend [4] - Shareholders can appoint a proxy to attend and vote on their behalf [4] Registration Details - Registration for the meeting will take place on May 30, 2025, from 9:30 to 11:30 and 13:00 to 15:00 [5] - Registration can be done via mail, fax, or in person, with specific documentation required [5][6] Meeting Agenda - The meeting will review proposals that have been approved by the company's board and supervisory board on May 14, 2025 [2] - Related shareholders who need to abstain from voting include Tao Chunfeng and Ningbo Dinghong Venture Capital Partnership [2]

甬兴证券有限公司（以下简称"甬兴证券"或"保荐机构"）作为宁波长鸿高分 子科技股份有限公司（以下简称"长鸿高科"或"公司")向特定对象发行股票的持 续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所股 票上市规则》《上海证券交易所上市公司自律监管指引第 1 号—规范运作》及《上 海证券交易所上市公司自律监管指引第 5 号—交易与关联交易》等相关法规的规 定，对长鸿高科补充确认日常关联交易事项进行了核查，现发表核查意见如下： 一、日常关联交易基本情况 （一）补充确认日常关联交易情况概述 2024 年度宁波长鸿高分子科技股份有限公司（以下简称"长鸿高科"或"公 司"）与浙江省宁波市华伟化工销售有限责任公司（以下简称"华伟化工"）之间 的关联交易金额为 19,552.55 万元，与年度预计金额 9,000 万元相比，超出 10,552.55 万元，现予以补充确认。由于超出金额超过 3,000 万元且占公司最近一 期经审计净资产的 5%以上，本次补充确认日常关联交易事项尚需提交股东会审 议。 甬兴证券有限公司关于宁波长鸿高分子科技股份有限公司 补充确认日常关联交易的核查意见 2025 年 5 月 1 ...

证券代码：605008 证券简称：长鸿高科 公告编号：2025-030 宁波长鸿高分子科技股份有限公司 关于补充确认日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次补充确认日常关联交易事项尚需提交股东会审议。 本次补充确认的日常关联交易为正常生产经营行为，根据交易双方业务 发展和生产经营实际需要进行，以市场价格为定价标准，遵循公开、公平、公正 的原则，不存在损害公司及全体股东尤其是中小股东利益的行为，不影响上市公 司的独立性，不会因此类交易而对关联人形成依赖。 一、日常关联交易基本情况 （一）补充确认日常关联交易情况概述 2024 年度宁波长鸿高分子科技股份有限公司（以下简称"长鸿高科"或"公 司"）与浙江省宁波市华伟化工销售有限责任公司（以下简称"华伟化工"）之 间的关联交易金额为 19,552.55 万元，与年度预计金额 9,000 万元相比，超出 10,552.55 万元，现予以补充确认。由于超出金额超过 3,000 万元且占公司最近一 期经审计净资产的 5%以上，本次补充确认 ...

证券代码：605008 证券简称：长鸿高科 公告编号：2025-031 宁波长鸿高分子科技股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 3 日 14 点 00 分 召开地点：浙江省宁波市鄞州区高新区新晖路 102 号 股东会召开日期：2025年6月3日 本次股东会采用的网络投票系统：上海证券交易所股东大会网络投票系 统 (一)股东会类型和届次 2025年第三次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 3 日 至2025 年 6 月 3 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15- ...

第三届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波长鸿高分子科技股份有限公司 证券代码：605008 证券简称：长鸿高科 公告编号：2025-029 表决情况：3 票同意，0 票反对，0 票弃权。 本议案尚需提交公司股东会审议。 特此公告。 宁波长鸿高分子科技股份有限公司 监事会 一、监事会会议召开情况 宁波长鸿高分子科技股份有限公司（以下简称"公司"）第三届监事会第十 三次会议（以下简称"本次会议"）于 2025 年 5 月 14 日以现场结合通讯方式召 开，本次会议通知已于会前通过电子邮件的方式送达公司全体监事。本次会议为 紧急会议，全体监事一致同意豁免本次会议的通知时限。本次会议由监事会主席 仲章明先生主持，会议应参加表决监事 3 人，实际参加表决监事 3 人。本次会 议的召集、召开符合《中华人民共和国公司法》等法律、法规和《宁波长鸿高分 子科技股份有限公司章程》的有关规定。会议决议合法、有效。 二、监事会会议审议情况 经与会监事审议，做出以下决议： （一）审议通过《关于补充确认日常关 ...